ENTITY
Pharmaron Beijing

Pharmaron Beijing (3759 HK)

147
Analysis
Health CareChina
Pharmaron Beijing Co., Ltd. engages in discovery, development, and manufacturing spectrum for small molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices and clinic research. The Company offers laboratory, clinical development, chemistry manufactory and control, and other services. Pharmaron Beijing conducts businesses based in China.
more
Refresh
02 Aug 2020 09:20

Haier (1169 HK): Avatar Scrip Offer From Parent

Haier Electronics Group Co (1169 HK) (HEG) was briefly suspended pursuant to the Takeovers Code on the 19 December 2019, which was followed by...

Logo
527 Views
Share
27 Jul 2020 15:34

Tigermed (泰格医疗) A+H: Past A+H Listings Suggest Upside Might Be Limited

Tigermed, the largest China-based clinical CRO company, launched book building today to raise up to USD 1.4 bn to list in Hong Kong.  In our...

Logo
389 Views
Share
27 Jul 2020 14:38

Tigermed IPO: Valuation Insights

Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
412 Views
Share
20 Jul 2020 18:52

Tigermed (泰格医疗) A+H: PHIP Updates and Thoughts on Valuation

Hangzhou Tigermed, a leading China-based CRO company, is seeking a USD 1.5 bn H-share listing in Hong Kong. In our previous note, we discussed that...

Logo
418 Views
Share
20 Jul 2020 01:00

Tigermed IPO: PHIP Highlights the Trade-Offs

Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
370 Views
Share
x